These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2118055)

  • 21. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
    Mills LE; Ball ED; Howell AL; Cornwell GG; Thompson L; Spruce W; Miller WE; McMillan R
    Prog Clin Biol Res; 1990; 333():165-70. PubMed ID: 2308980
    [No Abstract]   [Full Text] [Related]  

  • 22. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Atta J; Martin H; Bruecher J; Elsner S; Wassmann B; Rode C; Russ A; Kvalheim G; Hoelzer D
    Bone Marrow Transplant; 1996 Sep; 18(3):541-8. PubMed ID: 8879615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autologous bone marrow transplantation in children with acute leukemia].
    Matsuyama T; Kojima S; Miyajima Y; Fukuda M
    Rinsho Ketsueki; 1990 Oct; 31(10):1626-32. PubMed ID: 2255054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
    Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
    Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
    Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K
    Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
    Janssen WE; Lee C; Gross S; Gee AP
    Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
    Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
    Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
    Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
    [No Abstract]   [Full Text] [Related]  

  • 33. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
    Jándula BM; Nomdedeu J; Marín P; Vivancos P
    Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.
    Beaujean F; Bernaudin F; Kuentz M; Lemerle S; Cordonnier C; Le Forestier C; Reinert P; Duedari N; Brandely M; Vernant JP
    Bone Marrow Transplant; 1995 May; 15(5):691-6. PubMed ID: 7670397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
    Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
    Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive detection of residual acute lymphoblastic leukemia cells for monitoring bone marrow purging.
    Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
    Transplant Proc; 1990 Oct; 22(5):2175-6. PubMed ID: 2219334
    [No Abstract]   [Full Text] [Related]  

  • 37. CD9 is an unreliable antibody for bone marrow purging.
    Fort JA; Rios AM; Gross S; Janssen WE
    Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Peters SO; Stockschläder M; Hegewisch-Becker S; Krüger W; Weh HJ; Hossfeld DK; Zander AR
    Bone Marrow Transplant; 1995 May; 15(5):783-4. PubMed ID: 7670406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymerase chain reaction: a method for monitoring tumor cell purge by long-term culture in BCR/ABL positive acute lymphoblastic leukemia.
    Fabrega S; Laporte JP; Giarratana MC; Douay L; Fouillard L; Da WM; Perrot C; Barbu V; Gorin NC
    Bone Marrow Transplant; 1993 Feb; 11(2):169-73. PubMed ID: 8435666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.